Search Results 111-120 of 15937 for SC

  1. C. difficile infection - Symptoms and causes - Mayo Clinic

    Learn more about this diarrhea-causing infection that often occurs after antibiotic use. Many, but not all, people who get it are in health care facilities.

  2. Publications - Courtney E. Bennett, D.O. - Mayo Clinic

    Porter J, Larson EM, Bennett CE, Liedl CP, Churchill JT, Berns KS, Konz BA, Eastman SC, Rentz LC, Juntunen MB, Johnson MP, Laudon DA. Improving Efficiencies ...

  3. Publications - Harry E. Fuentes Bayne, M.D., M.S. - Mayo Clinic

    Publications. Print. Yin LX, Hidalgo CM, Bogan AW, Hunter DE, Bartemes KR, Tasche KK, Moore EJ, Price DL, Ma DJ, Neben-Wittich MA, Lester SC, Price KA ...

  4. Publications - Debra A. Bell, M.D. - Mayo Clinic

    Wertheim I, Muto MG, Welch WR, Bell DA, Berkowitz RS, Mok SC. p53 gene mutation in human borderline epithelial ovarian tumors. J Natl Cancer Inst. 1994 Oct 19; ...

  5. Publications - Sandra M. Herrmann, M.D. - Mayo Clinic

    ... SC, Hickson TJ, van Wijnen AJ, Eirin A, Lerman LO, Herrmann SM. Effect of ... SC, Lerman LO. Diabetic Kidney Disease Alters the Transcriptome and ...

  6. Publications - Vinaya Simha, M.B.B.S., M.D. - Mayo Clinic

    Simha V, LoPiccolo MK, Platt A, Brown RJ, Johnson X, Carere DA, Donnelly C, Snyder MT, Xing C, Mathews TP, Gopal P, Ward SC, Tomchick DR, Agarwal AK, ...

  7. Publications - Gretchen E. Glaser, M.D. - Mayo Clinic

    ... SC, Glaser GE. Implementation of enhanced recovery protocol did not increase rates of acute kidney injury in open gynecologic oncology surgery: A single ...

  8. Pegfilgrastim (subcutaneous route) - Mayo Clinic

    Pegfilgrastim injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...

  9. Biomarkers for Cancer Early Detection and Survival Prediction Study - Hepatobiliary Cancer Laboratory - Mayo Clinic Research

    Bile Biomarkers for Detecting IgG4-Related Sclerosing Cholangitis. IgG4-sclerosing cholangitis (IgG4-SC) can be difficult to distinguish from primary sclerosing ...

  10. A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens - Mayo Clinic

    The purpose of this study is to evaluate the clinical benefit of subcutaneous (SC) daratumumab administered in combination with standard multiple myeloma ...